Liver fat in children with celiac disease
Official title: Liver Steatosis in Pediatric Celiac Disease Patients: Exploring the Epidemiological and Pathophysiological Features of an Underestimated Condition
Run by University of Palermo · NCT06206616 · Data updated 2026-11-12
This study will try to see if children with celiac disease have fatty liver and how their liver tests and markers change with a gluten-free diet.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Year to 14 Years |
| Sex | All |
| Enrollment | 91 (estimated) |
| Sponsor | University of Palermo Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (Palermo, Palermo and 1 other locations) |
| Status | Recruiting |
| Started | November 1, 2027 |
| Main results expected | December 31, 2027 |
| Study ends | September 30, 2028 |
| Registry record updated | May 1, 2026 |
| Trial ID | NCT06206616 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 1–14 years with a confirmed celiac disease diagnosis by ESPGHAN criteria who can attend visits at the study site and follow the gluten-free diet guidance are ideal candidates.
✕Probably not a fit
Children with other chronic liver or gastrointestinal diseases, active bacterial/parasitic infections, cancer, immunodeficiency, or those unwilling to reintroduce gluten for diagnostic purposes are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will examine how often and in what form liver steatosis occurs in children with celiac disease, including related measures of intestinal permeability and inflammatory cytokines. It will enroll children aged 1–14 with celiac disease diagnosed according to ESPGHAN criteria and collect clinical data, blood tests, and liver imaging and biomarker measurements. Investigators will relate liver findings to nutritional status and follow liver test changes after starting or maintaining a gluten-free diet. Children with active infections, other chronic gastrointestinal or systemic diseases, cancer, or undergoing chemotherapy/radiotherapy are excluded.
Why it matters
Potential benefit: If successful, this could help find children with celiac disease who have fatty liver earlier so they can get appropriate dietary guidance and liver monitoring.
How similar studies have gone: Adult studies have shown a non-random association between celiac disease and NAFLD, but pediatric data are limited and have produced mixed results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>1 and \<14 years * Celiac Disease diagnosis according European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) criteria Exclusion Criteria: * age \<1 and \>14 years; * self-exclusion of gluten/wheat from the diet and refusal to reintroduce it, for diagnostic purposes, before entering the study; * bacterial and/or parasitic infections; * diagnosis of chronic inflammatory intestinal diseases and other organic pathologies affecting the digestive system (for example, serious liver diseases), nervous system diseases, immunological deficits and impairments that limit physical activity; * diagnosis of cancer * patients undergoing chemotherapy and/or radiotherapy.
Where it's running
-
Gastroenterological Paediatrics, Children's Hospital "G. Di Cristina"
Palermo, Palermo, Italy Recruiting -
General Pediatrics Unit, Children's Hospital "G. Di Cristina"
Palermo, Palermo, Italy Recruiting
Study contacts
- Study coordinator: Aurelio Seidita, MD
- Email: aurelio.seidita@unipa.it
- Phone: 00390916802764
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nutrition and physical activity education for children with celiac disease
This study tests whether a combined nutrition and physical activity education program helps 8- to 12-year-olds with celiac disease improve body health, eating habits, activity, and quality of life while on a gluten-free diet.
-
Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk
This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.
-
Additive Physical Activity for Hypothyroidism in Older Women with Glaucoma and Fatty Liver
We’re testing whether adding a treadmill-based exercise program to standard thyroid treatment helps improve health in older women who have subclinical hypothyroidism, glaucoma, and fatty liver.
-
Sucrosomial iron for children with celiac disease and iron deficiency
This trial tests whether adding oral Sucrosomial® (Sideral forte®) iron drops to a gluten-free diet helps children aged 8–18 with newly diagnosed celiac disease and low iron or anemia recover hemoglobin and iron stores faster than diet alone.
-
Lowering insulin to reduce liver fat production
This study will try a short course of diazoxide to lower insulin and see if it reduces the liver's creation of new fat in adults with obesity, insulin resistance, and MASLD.
-
Adherence to a Gluten-Free Diet and How it Relates to Thinking and Movement in Teens with Celiac Disease
This study tests whether following a gluten-free diet affects thinking speed, attention, memory, and motor skills in adolescents with celiac disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.